Fig. 5
From: Modelling population-level impact to inform target product profiles for childhood malaria vaccines
Population-level impact of the three efficacy scenarios in Fig. 4. Cumulative clinical cases averted over a 10-year period, per 1000 individuals, stratified by prevalence setting and efficacy profile. The bars show the median estimates, and the error bars show 95% credible intervals, based on 50 parameter draws. PfPR2–10 represents P. falciparum prevalence for 2–10-year-old individuals, prior to vaccination